Free Trial

ESGEN Acquisition (ESACW) Financials

$0.03 +0.00 (+18.35%)
As of 10/15/2026
Annual Income Statements for ESGEN Acquisition

Annual Income Statements for ESGEN Acquisition

This table shows ESGEN Acquisition's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
14 4.85 -2.67 -14
Consolidated Net Income / (Loss)
14 4.85 -9.87 -20
Net Income / (Loss) Continuing Operations
14 4.85 -9.87 -20
Total Pre-Tax Income
14 4.85 -11 -19
Total Operating Income
-2.83 5.14 -11 -21
Total Gross Profit
0.00 50 35 38
Total Revenue
0.00 110 73 69
Operating Revenue
- 110 73 69
Total Cost of Revenue
0.00 59 38 31
Operating Cost of Revenue
- 59 38 31
Total Operating Expenses
2.83 45 46 59
Selling, General & Admin Expense
0.80 13 22 28
Marketing Expense
- 30 20 23
Depreciation Expense
- 1.84 4.84 8.58
Other Special Charges / (Income)
1.91 - -0.09 0.00
Total Other Income / (Expense), net
17 -0.29 -0.12 1.17
Interest Expense
- 0.11 0.33 0.16
Other Income / (Expense), net
13 -0.18 0.21 1.32
Income Tax Expense
- 0.00 -0.96 0.26
Net Income / (Loss) Attributable to Noncontrolling Interest
- 0.00 -6.68 -5.62
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- 0.00 -0.52 0.00
Basic Earnings per Share
$0.74 $4.85 ($0.48) ($0.56)
Weighted Average Basic Shares Outstanding
34.50M 1M 5.55M 24.94M
Diluted Earnings per Share
- $4.85 ($0.48) ($0.56)
Weighted Average Diluted Shares Outstanding
9.80M 1M 5.55M 24.94M
Weighted Average Basic & Diluted Shares Outstanding
9.80M 40.26M - 57.97M

Quarterly Income Statements for ESGEN Acquisition

This table shows ESGEN Acquisition's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
4.85 -1.53 -0.28 -0.42 -0.44 -6.36 -2.42 -3.23 -2.01 -3.51 -2.34
Consolidated Net Income / (Loss)
-1.60 -4.11 -1.76 -2.87 -1.14 -13 -2.68 -1.87 -1.76 -4.69 -2.75
Net Income / (Loss) Continuing Operations
-1.60 -4.11 -1.76 -2.87 -1.14 -13 -2.68 -1.87 -1.76 -4.69 -2.75
Total Pre-Tax Income
-1.60 -4.22 -1.83 -2.92 -1.86 -13 -2.87 -1.82 -1.88 -4.78 -2.65
Total Operating Income
-1.36 -4.05 -2.66 -2.98 -1.11 -14 -2.85 -1.98 -2.19 -4.77 -2.99
Total Gross Profit
-7.68 6.18 7.74 9.87 11 3.99 11 14 9.63 5.60 7.62
Total Revenue
23 20 15 20 19 8.78 18 24 19 13 16
Operating Revenue
23 20 15 20 19 8.78 18 24 19 13 16
Total Cost of Revenue
31 14 7.06 9.79 7.26 4.79 7.28 10 8.94 7.58 8.55
Operating Cost of Revenue
- 14 7.06 9.79 7.26 4.79 7.28 10 8.94 7.58 8.55
Total Operating Expenses
-6.32 10 10 13 12 18 14 16 12 10 11
Selling, General & Admin Expense
-17 3.22 5.52 7.15 5.66 9.49 4.87 5.99 6.22 6.28 5.95
Marketing Expense
11 6.55 4.42 5.20 3.41 3.11 5.63 9.59 5.34 3.01 4.42
Depreciation Expense
0.41 0.46 0.45 0.50 3.42 4.90 3.18 0.25 0.25 1.08 0.25
Total Other Income / (Expense), net
-0.24 -0.17 0.83 0.07 -0.85 0.72 -0.01 0.16 0.30 -0.02 0.34
Interest Expense
0.05 0.04 0.05 0.21 0.04 0.03 -0.03 0.13 0.03 0.01 0.03
Other Income / (Expense), net
-0.19 -0.14 0.88 0.28 -0.81 0.75 -0.04 0.29 0.33 -0.01 0.37
Income Tax Expense
- -0.11 -0.08 -0.04 -0.73 0.52 -0.19 0.05 -0.12 -0.09 0.10
Net Income / (Loss) Attributable to Noncontrolling Interest
- -2.05 -1.48 -2.45 -0.70 -6.96 -0.26 1.36 0.25 -1.18 -0.41
Basic Earnings per Share
$4.85 ($1.54) ($0.06) ($0.08) $1.20 ($0.48) ($0.11) ($0.12) $0.15 ($0.11) ($0.07)
Weighted Average Basic Shares Outstanding
1M 994.35K 5.03M 5.05M 5.55M 13.25M 22.10M 27.31M 24.94M 33.38M 35.19M
Diluted Earnings per Share
$4.85 ($1.54) ($0.06) ($0.08) $1.20 ($0.48) ($0.11) ($0.12) $0.15 ($0.11) ($0.07)
Weighted Average Diluted Shares Outstanding
1M 994.35K 5.03M 5.05M 5.55M 13.25M 22.10M 27.31M 24.94M 33.38M 35.84M
Weighted Average Basic & Diluted Shares Outstanding
40.26M 41.04M 41.04M - 0.00 49.30M 54.83M 57.53M 57.97M 58.02M 58.78M

Annual Cash Flow Statements for ESGEN Acquisition

This table details how cash moves in and out of ESGEN Acquisition's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-0.71 5.75 -2.39 0.50
Net Cash From Operating Activities
3.28 12 -8.72 -8.69
Net Cash From Continuing Operating Activities
3.28 12 -8.72 -8.69
Net Income / (Loss) Continuing Operations
14 4.85 -9.87 -20
Consolidated Net Income / (Loss)
14 4.85 -9.87 -20
Depreciation Expense
- 1.84 4.84 8.58
Amortization Expense
- - 0.00 0.06
Non-Cash Adjustments To Reconcile Net Income
-13 -2.10 10 7.21
Changes in Operating Assets and Liabilities, net
2.12 7.39 -14 -4.91
Net Cash From Investing Activities
-3.98 -1.03 -7.37 13
Net Cash From Continuing Investing Activities
-3.98 -1.03 -7.37 13
Purchase of Property, Plant & Equipment
- -1.03 -0.37 -1.22
Acquisitions
- - -4.00 0.00
Divestitures
- - 0.00 15
Other Investing Activities, net
- 0.00 -3.00 0.00
Net Cash From Financing Activities
0.00 -5.19 14 -4.17
Net Cash From Continuing Financing Activities
0.00 -5.19 14 -4.17
Repayment of Debt
- -0.24 -0.33 -3.38
Payment of Dividends
- -5.17 -0.23 -0.62
Issuance of Debt
0.00 0.31 2.44 0.00
Issuance of Preferred Equity
- 0.00 9.22 0.00
Issuance of Common Equity
- 0.00 2.72 0.00
Other Financing Activities, net
- -0.08 -0.12 -0.17
Cash Interest Paid
- 0.10 0.12 0.10
Cash Income Taxes Paid
- 0.00 0.00 0.00

Quarterly Cash Flow Statements for ESGEN Acquisition

This table details how cash moves in and out of ESGEN Acquisition's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
3.68 -0.29 -2.39 -1.01 1.30 -2.74 -2.83 3.85 2.22 -4.41 0.72
Net Cash From Operating Activities
6.31 -10 -2.20 0.16 3.47 -2.26 -2.29 -6.58 2.44 -0.85 -0.46
Net Cash From Continuing Operating Activities
6.31 -10 -2.17 0.16 3.47 -2.26 -2.05 -6.82 2.44 -0.85 -0.46
Net Income / (Loss) Continuing Operations
-1.60 -4.11 -1.76 -2.87 -1.14 -13 -2.68 -1.87 -1.76 -4.69 -2.75
Consolidated Net Income / (Loss)
-1.60 -4.11 -1.76 -2.87 -1.14 -13 -2.68 -1.87 -1.76 -4.69 -2.75
Depreciation Expense
0.48 0.46 0.45 0.50 3.42 4.89 3.18 0.25 0.25 1.08 0.25
Amortization Expense
- - - - - 0.02 - - 0.02 0.00 0.02
Non-Cash Adjustments To Reconcile Net Income
-3.14 6.76 -1.29 5.72 -0.88 5.14 -1.85 -0.97 4.86 1.18 0.92
Changes in Operating Assets and Liabilities, net
11 -13 0.43 -3.19 2.06 1.01 -0.69 -4.28 -0.92 1.58 1.10
Net Cash From Investing Activities
-0.87 -0.23 -0.10 0.05 -7.08 -0.37 -0.43 14 -0.18 -3.36 -0.20
Net Cash From Continuing Investing Activities
-0.87 -0.23 -0.10 0.05 -7.08 -0.37 -0.43 14 -0.18 -3.36 -0.20
Purchase of Property, Plant & Equipment
-0.87 -0.23 -0.10 0.05 -0.08 -0.37 -0.43 -0.24 -0.18 -0.21 -0.20
Net Cash From Financing Activities
-1.76 10 -0.08 -1.22 4.92 -0.10 -0.10 -3.92 -0.04 -0.20 1.38
Net Cash From Continuing Financing Activities
-1.76 10 -0.08 -1.22 4.92 -0.10 -0.10 -3.92 -0.04 -0.20 1.38
Repayment of Debt
0.09 -0.10 -0.03 -0.22 0.02 -0.10 -0.14 -3.14 -0.04 -0.04 -0.10
Other Financing Activities, net
- - - 0.06 -0.12 0.00 - - -0.01 -0.01 -0.02
Cash Interest Paid
0.06 0.03 0.03 0.08 -0.01 0.03 0.02 0.04 0.01 0.01 0.01

Annual Balance Sheets for ESGEN Acquisition

This table presents ESGEN Acquisition's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
283 286 48 61 57
Total Current Assets
1.87 0.65 16 19 23
Cash & Equivalents
1.32 0.61 8.02 5.63 6.14
Accounts Receivable
- - 2.91 9.19 8.77
Inventories, net
- - 0.35 0.87 0.85
Prepaid Expenses
0.55 0.03 0.04 2.11 4.19
Other Current Assets
- - 4.92 1.09 2.60
Plant, Property, & Equipment, net
0.00 0.00 2.29 2.48 2.83
Total Noncurrent Assets
282 286 30 40 32
Noncurrent Note & Lease Receivables
- - 0.58 3.45 3.46
Goodwill
- - 27 27 27
Other Noncurrent Operating Assets
282 - 1.20 1.34 0.99
Total Liabilities & Shareholders' Equity
283 286 48 61 57
Total Liabilities
24 13 17 18 9.45
Total Current Liabilities
0.61 2.18 16 15 8.39
Short-Term Debt
0.17 0.17 0.29 3.31 0.71
Accounts Payable
- 1.87 4.70 2.78 3.77
Accrued Expenses
0.41 - 4.65 8.54 2.42
Other Current Liabilities
0.02 0.14 0.66 0.33 1.49
Total Noncurrent Liabilities
24 10 1.94 3.09 1.06
Long-Term Debt
- - 0.83 0.50 0.06
Capital Lease Obligations
- - 0.48 1.15 0.51
Other Noncurrent Operating Liabilities
24 10 0.64 1.45 0.49
Redeemable Noncontrolling Interest
282 286 - 16 17
Total Equity & Noncontrolling Interests
-22 -12 31 27 30
Total Preferred & Common Equity
-22 -12 31 -89 5.33
Total Common Equity
-22 -12 31 27 30
Common Stock
0.00 0.00 31 130 88
Retained Earnings
-22 -12 -0.53 -103 -58
Accumulated Other Comprehensive Income / (Loss)
- - - 0.00 -0.00

Quarterly Balance Sheets for ESGEN Acquisition

This table presents ESGEN Acquisition's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
33 50 47 47 47 46 59 57 56
Total Current Assets
0.27 18 16 16 10 11 24 20 20
Cash & Equivalents
0.27 7.73 5.34 4.33 2.89 0.07 3.92 1.73 2.45
Accounts Receivable
- 7.75 7.53 8.52 5.00 5.55 11 11 10
Inventories, net
- 0.38 0.44 0.48 0.85 0.92 0.93 0.85 0.82
Prepaid Expenses
0.00 2.60 2.72 2.25 0.94 1.58 1.59 3.98 4.04
Other Current Assets
- - - - 0.58 2.78 6.09 2.34 2.00
Plant, Property, & Equipment, net
0.00 2.35 2.29 2.13 2.63 2.85 2.87 1.99 1.98
Total Noncurrent Assets
32 29 29 29 32 32 29 35 34
Noncurrent Note & Lease Receivables
- 0.55 0.52 0.48 0.41 3.38 0.34 6.62 6.63
Goodwill
- 27 27 27 27 27 27 27 27
Other Noncurrent Operating Assets
32 1.22 1.15 1.89 1.20 2.10 1.16 0.80 0.66
Total Liabilities & Shareholders' Equity
33 50 47 47 47 46 59 57 56
Total Liabilities
8.02 16 12 14 16 16 12 13 15
Total Current Liabilities
7.02 11 8.40 10 14 14 11 12 13
Short-Term Debt
1.41 0.30 0.31 0.29 2.76 3.34 2.51 0.64 0.52
Accounts Payable
5.30 5.45 3.39 4.86 3.57 5.05 3.45 5.01 4.72
Accrued Expenses
- 3.90 3.76 3.56 6.58 5.47 2.84 5.70 3.15
Other Current Liabilities
0.31 0.61 0.51 0.70 0.69 0.34 0.86 0.77 4.17
Total Noncurrent Liabilities
1.00 4.88 3.90 3.55 2.18 2.07 33 0.98 2.10
Long-Term Debt
- 0.75 0.69 0.57 0.41 0.34 0.06 0.05 0.57
Capital Lease Obligations
- 0.45 0.42 0.38 0.31 0.85 - 0.37 0.30
Other Noncurrent Operating Liabilities
1.00 3.69 2.80 2.60 1.45 0.88 32 0.57 1.23
Redeemable Noncontrolling Interest
32 15 15 16 17 17 17 17 18
Total Equity & Noncontrolling Interests
-7.75 19 19 18 15 13 -1.72 26 23
Total Preferred & Common Equity
-7.75 -173 -53 -39 -23 -59 -1.72 14 9.26
Total Common Equity
-7.75 19 19 18 15 13 -1.72 26 23
Common Stock
0.00 192 75 61 55 109 60 77 80
Retained Earnings
-7.75 -173 -55 -43 -40 -96 -62 -51 -56
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -0.00 0.01 0.02

Annual Metrics And Ratios for ESGEN Acquisition

This table displays calculated financial ratios and metrics derived from ESGEN Acquisition's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
34,500,000.00 8,308,555.00 40,256,964.00 40,256,964.00
DEI Adjusted Shares Outstanding
34,500,000.00 8,308,555.00 40,256,964.00 40,256,964.00
DEI Earnings Per Adjusted Shares Outstanding
0.42 0.58 -0.07 -0.35
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% -33.23% -5.32%
EBITDA Growth
0.00% -34.32% -184.70% -83.65%
EBIT Growth
0.00% -52.12% -313.77% -81.33%
NOPAT Growth
0.00% 281.59% -247.17% -90.03%
Net Income Growth
0.00% -66.20% -303.76% -98.83%
EPS Growth
0.00% 0.00% -109.90% -16.67%
Operating Cash Flow Growth
0.00% 265.68% -172.78% 0.29%
Free Cash Flow Firm Growth
0.00% 0.00% 18.72% 42.38%
Invested Capital Growth
0.00% 294.59% 74.54% 0.90%
Revenue Q/Q Growth
0.00% 26.51% -5.59% -0.12%
EBITDA Q/Q Growth
0.00% -0.18% 30.95% -41.86%
EBIT Q/Q Growth
0.00% -27.23% -3.59% -0.04%
NOPAT Q/Q Growth
0.00% -1.77% 2.24% -5.40%
Net Income Q/Q Growth
0.00% -46.80% 4.46% -3.29%
EPS Q/Q Growth
0.00% 0.00% -115.14% -214.29%
Operating Cash Flow Q/Q Growth
0.00% 27.75% -48.28% -13.46%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -106.53% -341.60%
Invested Capital Q/Q Growth
0.00% -6.17% 38.71% 298.00%
Profitability Metrics
- - - -
Gross Margin
0.00% 45.81% 48.03% 55.20%
EBITDA Margin
0.00% 6.20% -7.86% -15.25%
Operating Margin
0.00% 4.69% -14.75% -29.61%
EBIT Margin
0.00% 4.52% -14.46% -27.70%
Profit (Net Income) Margin
0.00% 4.42% -13.48% -28.31%
Tax Burden Percent
100.00% 100.00% 91.11% 101.36%
Interest Burden Percent
138.50% 97.76% 102.28% 100.81%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 87.38% -22.77% -33.88%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 87.58% 42.30% 156.06%
Return on Net Nonoperating Assets (RNNOA)
0.00% -84.19% -4.08% -9.56%
Return on Equity (ROE)
5.38% 3.19% -26.85% -43.43%
Cash Return on Invested Capital (CROIC)
0.00% -130.15% -77.07% -34.77%
Operating Return on Assets (OROA)
0.00% 2.97% -19.43% -32.59%
Return on Assets (ROA)
0.00% 2.90% -18.10% -33.30%
Return on Common Equity (ROCE)
-0.35% 0.20% -20.96% -27.41%
Return on Equity Simple (ROE_SIMPLE)
-119.52% 15.82% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-2.83 5.14 -7.56 -14
NOPAT Margin
0.00% 4.69% -10.33% -20.72%
Net Nonoperating Expense Percent (NNEP)
6.00% -0.20% -65.06% -189.94%
Return On Investment Capital (ROIC_SIMPLE)
- 15.95% -23.83% -45.56%
Cost of Revenue to Revenue
0.00% 54.19% 51.97% 44.80%
SG&A Expenses to Revenue
0.00% 11.81% 29.43% 39.71%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 41.13% 62.65% 84.81%
Earnings before Interest and Taxes (EBIT)
10 4.96 -11 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
10 6.80 -5.76 -11
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.37 0.71 0.90
Price to Tangible Book Value (P/TBV)
0.00 3.96 0.00 8.55
Price to Revenue (P/Rev)
0.00 0.10 0.26 0.39
Price to Earnings (P/E)
7.07 2.32 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
14.15% 43.03% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.20 0.82 0.93
Enterprise Value to Revenue (EV/Rev)
0.00 0.04 0.47 0.57
Enterprise Value to EBITDA (EV/EBITDA)
9.74 0.71 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
9.74 0.98 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.94 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
30.79 0.40 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.05 0.12 0.03
Long-Term Debt to Equity
0.00 0.04 0.04 0.01
Financial Leverage
-1.05 -0.96 -0.10 -0.06
Leverage Ratio
1.07 1.10 1.48 1.30
Compound Leverage Factor
1.48 1.07 1.52 1.32
Debt to Total Capital
0.06% 4.96% 10.36% 2.62%
Short-Term Debt to Total Capital
0.06% 0.91% 6.92% 1.45%
Long-Term Debt to Total Capital
0.00% 4.05% 3.44% 1.17%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
104.32% 0.00% 33.70% 35.29%
Common Equity to Total Capital
-4.38% 95.04% 55.94% 62.09%
Debt to EBITDA
0.02 0.24 -0.86 -0.12
Net Debt to EBITDA
-27.63 -0.94 0.12 0.46
Long-Term Debt to EBITDA
0.00 0.19 -0.29 -0.05
Debt to NOPAT
-0.06 0.31 -0.66 -0.09
Net Debt to NOPAT
101.04 -1.25 0.09 0.34
Long-Term Debt to NOPAT
0.00 0.25 -0.22 -0.04
Altman Z-Score
4.86 3.01 -1.04 0.70
Noncontrolling Interest Sharing Ratio
106.45% 93.87% 21.94% 36.88%
Liquidity Ratios
- - - -
Current Ratio
0.30 1.05 1.26 2.69
Quick Ratio
0.28 0.70 0.99 1.78
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -31 -26 -15
Operating Cash Flow to CapEx
0.00% 1,157.58% -2,361.38% -710.43%
Free Cash Flow to Firm to Interest Expense
0.00 -284.12 -76.76 -94.87
Operating Cash Flow to Interest Expense
0.00 108.04 -26.13 -55.90
Operating Cash Flow Less CapEx to Interest Expense
0.00 98.71 -27.24 -63.77
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.66 1.34 1.18
Accounts Receivable Turnover
0.00 0.00 12.11 7.72
Inventory Turnover
0.00 0.00 62.26 36.03
Fixed Asset Turnover
0.00 0.00 30.74 26.14
Accounts Payable Turnover
0.00 18.10 10.18 9.49
Days Sales Outstanding (DSO)
0.00 0.00 30.13 47.26
Days Inventory Outstanding (DIO)
0.00 0.00 5.86 10.13
Days Payable Outstanding (DPO)
0.00 20.16 35.86 38.48
Cash Conversion Cycle (CCC)
0.00 -20.16 0.13 18.91
Capital & Investment Metrics
- - - -
Invested Capital
-12 24 42 43
Invested Capital Turnover
0.00 18.65 2.20 1.63
Increase / (Decrease) in Invested Capital
0.00 37 18 0.38
Enterprise Value (EV)
101 4.84 34 40
Market Capitalization
101 11 19 27
Book Value per Share
($0.35) $3.69 $4.83 $1.21
Tangible Book Value per Share
($0.35) $0.34 ($1.41) $0.13
Total Capital
274 32 48 49
Total Debt
0.17 1.60 4.96 1.28
Total Long-Term Debt
0.00 1.31 1.64 0.57
Net Debt
-286 -6.42 -0.67 -4.86
Capital Expenditures (CapEx)
0.00 1.03 0.37 1.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.98 -7.02 1.60 8.73
Debt-free Net Working Capital (DFNWC)
-1.37 1.01 7.23 15
Net Working Capital (NWC)
-1.54 0.71 3.92 14
Net Nonoperating Expense (NNE)
-17 0.29 2.31 5.26
Net Nonoperating Obligations (NNO)
-286 -6.42 -0.67 -4.86
Total Depreciation and Amortization (D&A)
0.00 1.84 4.84 8.64
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -6.40% 2.18% 12.59%
Debt-free Net Working Capital to Revenue
0.00% 0.92% 9.88% 21.44%
Net Working Capital to Revenue
0.00% 0.65% 5.35% 20.42%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.74 $0.00 ($0.48) ($0.56)
Adjusted Weighted Average Basic Shares Outstanding
34.50M 0.00 5.55M 24.94M
Adjusted Diluted Earnings per Share
$0.74 $0.00 ($0.48) ($0.56)
Adjusted Weighted Average Diluted Shares Outstanding
34.50M 0.00 5.55M 24.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
9.80M 0.00 0.00 57.97M
Normalized Net Operating Profit after Tax (NOPAT)
-0.64 3.60 -7.63 -14
Normalized NOPAT Margin
0.00% 3.28% -10.41% -20.72%
Pre Tax Income Margin
0.00% 4.42% -14.79% -27.93%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 44.71 -31.76 -123.55
NOPAT to Interest Expense
0.00 46.36 -22.68 -92.43
EBIT Less CapEx to Interest Expense
0.00 35.37 -32.87 -131.42
NOPAT Less CapEx to Interest Expense
0.00 37.03 -23.78 -100.30
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 106.78% -2.32% -3.16%
Augmented Payout Ratio
0.00% 106.78% -2.32% -3.16%

Quarterly Metrics And Ratios for ESGEN Acquisition

This table displays calculated financial ratios and metrics derived from ESGEN Acquisition's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
8,308,555.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00
DEI Adjusted Shares Outstanding
8,308,555.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00 40,256,964.00
DEI Earnings Per Adjusted Shares Outstanding
0.58 -0.04 -0.01 -0.01 -0.01 -0.16 -0.06 -0.08 -0.05 -0.09 -0.06
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 7.53% -50.81% -48.12% -18.87% -56.39% 22.34% 21.56% -0.43% 50.11% -10.68%
EBITDA Growth
-410.97% -281.20% -201.01% -149.55% 240.37% -111.02% 120.97% 34.70% -205.61% 53.07% -943.99%
EBIT Growth
-548.59% -356.35% -307.16% -167.51% -23.73% -204.92% -62.35% 37.54% 3.07% 62.61% 9.52%
NOPAT Growth
22.44% -274.07% -314.66% -152.18% 18.25% -233.73% -7.16% 33.60% -96.91% 64.73% -4.75%
Net Income Growth
-159.21% -354.67% -311.97% -171.81% 28.89% -224.30% -52.47% 34.92% -55.11% 64.78% -2.63%
EPS Growth
0.00% 0.00% 0.00% 0.00% -75.26% 68.83% -83.33% -50.00% -87.50% 77.08% 36.36%
Operating Cash Flow Growth
70.15% -768.41% -710.93% -95.75% -44.97% 77.70% -3.94% -4,158.19% -29.70% 62.32% 79.82%
Free Cash Flow Firm Growth
0.00% -105.84% -103.40% -102.72% 49.94% 27.66% 34.49% 372.04% 89.85% -60.67% -47.01%
Invested Capital Growth
294.59% 72.00% 25.83% 18.07% 74.54% 3.88% 10.94% -64.84% 0.90% 46.70% 16.95%
Revenue Q/Q Growth
-39.34% -12.37% -26.54% 32.86% -5.14% -52.90% 106.09% 32.01% -22.30% -28.99% 22.64%
EBITDA Q/Q Growth
-124.10% -247.13% 64.30% -65.93% 168.27% -621.85% 103.55% -616.68% -10.41% -131.91% 36.20%
EBIT Q/Q Growth
-138.62% -170.30% 57.39% -51.75% 29.22% -566.14% 77.31% 41.62% -9.84% -156.94% 45.09%
NOPAT Q/Q Growth
-123.77% -198.03% 34.23% -12.02% 62.77% -1,116.70% 78.88% 30.59% -10.41% -117.91% 37.27%
Net Income Q/Q Growth
-139.92% -157.21% 57.21% -63.45% 60.47% -1,072.98% 79.88% 30.23% 5.78% -166.35% 41.38%
EPS Q/Q Growth
0.00% -131.75% 96.10% -33.33% 1,600.00% -140.00% 77.08% -9.09% 225.00% -173.33% 36.36%
Operating Cash Flow Q/Q Growth
65.33% -260.87% 78.33% 107.37% 2,040.87% -165.18% -1.02% -187.91% 137.09% -134.93% 45.89%
Free Cash Flow Firm Q/Q Growth
-115.14% 61.21% 43.54% 18.02% -178.86% 43.95% 48.88% 440.44% -110.40% -787.68% 53.22%
Invested Capital Q/Q Growth
-6.17% 15.94% 10.56% -1.84% 38.71% -31.00% 18.07% -68.89% 298.00% 0.33% -5.87%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-33.40% 30.70% 52.29% 50.21% 61.06% 45.47% 59.76% 57.93% 51.86% 42.51% 47.15%
EBITDA Margin
-4.67% -18.50% -8.99% -11.23% 8.08% -89.54% 1.54% -6.03% -8.57% -27.99% -14.56%
Operating Margin
-5.91% -20.10% -18.00% -15.17% -5.96% -153.82% -15.76% -8.29% -11.78% -36.14% -18.49%
EBIT Margin
-6.74% -20.79% -12.06% -13.77% -10.28% -145.33% -16.00% -7.08% -10.00% -36.20% -16.21%
Profit (Net Income) Margin
-6.95% -20.39% -11.88% -14.61% -6.09% -151.64% -14.80% -7.82% -9.49% -35.58% -17.01%
Tax Burden Percent
100.00% 97.28% 95.83% 98.49% 60.92% 104.09% 93.48% 102.68% 93.54% 98.07% 103.65%
Interest Burden Percent
103.10% 100.84% 102.79% 107.73% 97.27% 100.24% 98.96% 107.67% 101.37% 100.23% 101.24%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-77.15% -70.46% -43.36% -29.31% -9.19% -232.98% -21.99% -19.57% -13.48% -51.90% -24.89%
ROIC Less NNEP Spread (ROIC-NNEP)
-76.71% -28.82% -49.84% 51.31% 0.90% -143.64% -281.37% -6.58% -5.14% 35.90% -63.59%
Return on Net Nonoperating Assets (RNNOA)
73.74% 3.49% 2.79% -1.72% -0.09% 18.86% -2.28% 1.01% 0.31% -1.48% -3.03%
Return on Equity (ROE)
-3.41% -66.97% -40.58% -31.02% -9.28% -214.12% -24.27% -18.57% -13.16% -53.38% -27.93%
Cash Return on Invested Capital (CROIC)
-130.15% -54.63% -33.10% -44.08% -77.07% -53.41% -54.20% 29.67% -34.77% -60.81% -37.98%
Operating Return on Assets (OROA)
-4.42% -56.95% -29.27% -26.79% -13.80% -184.42% -22.32% -9.31% -11.77% -51.35% -22.78%
Return on Assets (ROA)
-4.56% -55.87% -28.83% -28.43% -8.18% -192.42% -20.65% -10.29% -11.16% -50.47% -23.90%
Return on Common Equity (ROCE)
-0.21% -5.95% -8.17% -5.29% -7.24% -111.32% -12.15% -6.10% -8.31% -29.16% -14.26%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.95 -2.83 -1.86 -2.09 -0.78 -9.46 -2.00 -1.39 -1.53 -3.34 -2.09
NOPAT Margin
-4.14% -14.07% -12.60% -10.62% -4.17% -107.68% -11.03% -5.80% -8.24% -25.30% -12.94%
Net Nonoperating Expense Percent (NNEP)
-0.44% -41.65% 6.47% -80.62% -10.09% -89.34% 259.38% -13.00% -8.33% -87.80% 38.70%
Return On Investment Capital (ROIC_SIMPLE)
-2.95% -13.68% -8.92% -11.04% -2.45% -51.11% -11.40% -163.43% -4.85% -12.35% -8.45%
Cost of Revenue to Revenue
133.40% 69.30% 47.71% 49.79% 38.94% 54.53% 40.24% 42.07% 48.14% 57.49% 52.85%
SG&A Expenses to Revenue
-75.00% 15.98% 37.33% 36.38% 30.37% 108.06% 26.88% 25.05% 33.51% 47.61% 36.79%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
-27.49% 50.80% 70.28% 65.39% 66.52% 199.29% 75.52% 66.22% 63.64% 78.65% 65.64%
Earnings before Interest and Taxes (EBIT)
-1.55 -4.19 -1.78 -2.71 -1.92 -13 -2.90 -1.69 -1.86 -4.77 -2.62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.07 -3.73 -1.33 -2.21 1.51 -7.86 0.28 -1.44 -1.59 -3.69 -2.35
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.37 0.30 0.55 0.48 0.71 1.33 4.93 0.00 0.90 0.74 1.01
Price to Tangible Book Value (P/TBV)
3.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.55 0.00 0.00
Price to Revenue (P/Rev)
0.10 0.05 0.11 0.11 0.26 0.32 0.98 0.53 0.39 0.26 0.33
Price to Earnings (P/E)
2.32 1.71 3.56 3.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
43.03% 58.46% 28.09% 30.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.20 0.52 0.72 0.70 0.82 1.27 2.48 4.88 0.93 0.84 1.01
Enterprise Value to Revenue (EV/Rev)
0.04 0.13 0.23 0.27 0.47 0.60 1.31 0.75 0.57 0.49 0.56
Enterprise Value to EBITDA (EV/EBITDA)
0.71 14.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.40 47.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.57 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.05 0.04 0.04 0.04 0.12 0.11 0.15 0.17 0.03 0.02 0.03
Long-Term Debt to Equity
0.04 0.03 0.03 0.03 0.04 0.02 0.04 0.00 0.01 0.01 0.02
Financial Leverage
-0.96 -0.12 -0.06 -0.03 -0.10 -0.13 0.01 -0.15 -0.06 -0.04 0.05
Leverage Ratio
1.10 1.61 1.34 1.37 1.48 1.48 1.44 2.17 1.30 1.39 1.43
Compound Leverage Factor
1.13 1.62 1.38 1.48 1.44 1.48 1.43 2.34 1.32 1.39 1.45
Debt to Total Capital
4.96% 4.18% 3.87% 3.57% 10.36% 9.94% 13.13% 14.58% 2.62% 2.37% 3.26%
Short-Term Debt to Total Capital
0.91% 0.84% 0.85% 0.84% 6.92% 7.87% 9.69% 14.23% 1.45% 1.43% 1.22%
Long-Term Debt to Total Capital
4.05% 3.34% 3.03% 2.73% 3.44% 2.08% 3.44% 0.35% 1.17% 0.94% 2.04%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 42.13% 42.53% 45.61% 33.70% 47.19% 49.18% 95.19% 35.29% 39.29% 41.98%
Common Equity to Total Capital
95.04% 53.69% 53.60% 50.82% 55.94% 42.86% 37.69% -9.77% 62.09% 58.34% 54.76%
Debt to EBITDA
0.24 1.48 -0.86 -0.15 -0.86 -0.35 -0.55 -0.34 -0.12 -0.16 -0.15
Net Debt to EBITDA
-0.94 -6.15 2.41 0.37 0.12 -0.06 -0.54 0.18 0.46 0.11 0.12
Long-Term Debt to EBITDA
0.19 1.18 -0.67 -0.11 -0.29 -0.07 -0.14 -0.01 -0.05 -0.07 -0.10
Debt to NOPAT
0.31 -3.98 -0.49 -0.16 -0.66 -0.25 -0.32 -0.19 -0.09 -0.13 -0.17
Net Debt to NOPAT
-1.25 16.58 1.38 0.40 0.09 -0.04 -0.31 0.10 0.34 0.08 0.13
Long-Term Debt to NOPAT
0.25 -3.18 -0.39 -0.12 -0.22 -0.05 -0.08 0.00 -0.04 -0.05 -0.10
Altman Z-Score
2.56 -2.50 0.98 0.69 -0.57 -0.08 0.56 1.66 1.71 0.80 0.84
Noncontrolling Interest Sharing Ratio
93.87% 91.11% 79.87% 82.93% 21.94% 48.01% 49.95% 67.17% 36.88% 45.36% 48.95%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.05 1.69 1.91 1.56 1.26 0.75 0.76 2.19 2.69 1.65 1.56
Quick Ratio
0.70 1.42 1.53 1.28 0.99 0.58 0.40 1.41 1.78 1.06 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-38 -15 -8.23 -6.75 -19 -11 -5.39 18 -1.91 -17 -7.93
Operating Cash Flow to CapEx
722.97% -4,490.52% -2,099.95% 0.00% 4,130.86% -607.51% -526.30% -2,735.66% 1,389.28% -415.33% -229.61%
Free Cash Flow to Firm to Interest Expense
-784.09 -413.90 -165.25 -32.25 -478.99 -348.34 0.00 141.50 -74.91 -1,561.39 -244.43
Operating Cash Flow to Interest Expense
131.65 -288.23 -44.16 0.78 88.41 -74.76 0.00 -50.75 95.81 -78.58 -14.23
Operating Cash Flow Less CapEx to Interest Expense
113.44 -294.65 -46.27 0.99 86.27 -87.06 0.00 -52.60 88.91 -97.50 -20.43
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.66 2.74 2.43 1.95 1.34 1.27 1.39 1.32 1.18 1.42 1.41
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 12.11 9.71 9.97 6.94 7.72 9.15 9.06
Inventory Turnover
0.00 0.00 0.00 0.00 62.26 47.12 42.93 41.41 36.03 39.78 40.41
Fixed Asset Turnover
0.00 0.00 0.00 0.00 30.74 24.87 25.37 27.78 26.14 31.94 29.77
Accounts Payable Turnover
18.10 14.73 12.83 12.11 10.18 6.41 6.89 7.07 9.49 7.89 7.19
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 30.13 37.59 36.61 52.63 47.26 39.90 40.28
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 5.86 7.75 8.50 8.81 10.13 9.18 9.03
Days Payable Outstanding (DPO)
20.16 24.77 28.44 30.14 35.86 56.95 52.97 51.64 38.48 46.25 50.78
Cash Conversion Cycle (CCC)
-20.16 -24.77 -28.44 -30.14 0.13 -11.62 -7.86 9.80 18.91 2.83 -1.47
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
24 28 31 30 42 29 34 11 43 43 40
Invested Capital Turnover
18.65 5.01 3.44 2.76 2.20 2.16 1.99 3.37 1.63 2.05 1.92
Increase / (Decrease) in Invested Capital
37 12 6.37 4.66 18 1.09 3.39 -20 0.38 14 5.83
Enterprise Value (EV)
4.84 15 22 21 34 37 85 52 40 36 41
Market Capitalization
11 5.67 11 8.54 19 20 64 37 27 19 24
Book Value per Share
$3.69 $19.32 $3.88 $3.50 $4.83 $1.13 $0.59 ($0.06) $1.21 $0.78 $0.66
Tangible Book Value per Share
$0.34 ($8.36) ($1.55) ($1.85) ($1.41) ($1.13) ($0.63) ($1.06) $0.13 ($0.03) ($0.11)
Total Capital
32 36 36 35 48 35 34 18 49 44 43
Total Debt
1.60 1.50 1.41 1.24 4.96 3.48 4.53 2.57 1.28 1.05 1.39
Total Long-Term Debt
1.31 1.20 1.10 0.95 1.64 0.73 1.19 0.06 0.57 0.42 0.87
Net Debt
-6.42 -6.23 -3.93 -3.09 -0.67 0.59 4.46 -1.35 -4.86 -0.68 -1.06
Capital Expenditures (CapEx)
0.87 0.23 0.10 -0.05 0.08 0.37 0.43 0.24 0.18 0.21 0.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-7.02 0.10 2.59 1.54 1.60 -3.60 -0.12 12 8.73 6.82 5.12
Debt-free Net Working Capital (DFNWC)
1.01 7.84 7.93 5.87 7.23 -0.70 -0.05 16 15 8.56 7.57
Net Working Capital (NWC)
0.71 7.54 7.62 5.58 3.92 -3.46 -3.39 13 14 7.92 7.05
Net Nonoperating Expense (NNE)
0.65 1.27 -0.11 0.78 0.36 3.86 0.68 0.48 0.23 1.36 0.66
Net Nonoperating Obligations (NNO)
-6.42 -6.23 -3.93 -3.09 -0.67 -2.41 4.46 -4.35 -4.86 -0.68 -1.06
Total Depreciation and Amortization (D&A)
0.48 0.46 0.45 0.50 3.42 4.90 3.18 0.25 0.27 1.08 0.27
Debt-free, Cash-free Net Working Capital to Revenue
-6.40% 0.09% 2.70% 1.98% 2.18% -5.82% -0.18% 16.70% 12.59% 9.25% 7.13%
Debt-free Net Working Capital to Revenue
0.92% 7.05% 8.28% 7.56% 9.88% -1.14% -0.08% 22.34% 21.44% 11.60% 10.55%
Net Working Capital to Revenue
0.65% 6.78% 7.96% 7.19% 5.35% -5.59% -5.21% 18.73% 20.42% 10.74% 9.82%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.85 $0.00 $0.00 ($0.08) $1.20 ($0.48) ($0.11) ($0.12) $0.15 ($0.11) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding
1M 0.00 0.00 5.05M 5.55M 13.25M 22.10M 27.31M 24.94M 33.38M 35.19M
Adjusted Diluted Earnings per Share
$4.85 $0.00 $0.00 ($0.08) $1.20 ($0.48) ($0.11) ($0.12) $0.15 ($0.11) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding
1M 0.00 0.00 5.05M 5.55M 13.25M 22.10M 27.31M 24.94M 33.38M 35.84M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
40.26M 0.00 0.00 0.00 0.00 49.30M 54.83M 57.53M 57.97M 58.02M 58.78M
Normalized Net Operating Profit after Tax (NOPAT)
-0.95 -2.83 -1.86 -2.09 -0.78 -9.46 -2.00 -1.39 -1.53 -3.34 -2.09
Normalized NOPAT Margin
-4.14% -14.07% -12.60% -10.62% -4.17% -107.68% -11.03% -5.80% -8.24% -25.30% -12.94%
Pre Tax Income Margin
-6.95% -20.96% -12.39% -14.84% -10.00% -145.68% -15.84% -7.62% -10.14% -36.28% -16.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-32.31 -118.86 -35.82 -12.94 -48.78 -421.63 0.00 -13.04 -72.89 -439.75 -80.82
NOPAT to Interest Expense
-19.84 -80.46 -37.42 -9.98 -19.79 -312.38 0.00 -10.69 -60.07 -307.34 -64.52
EBIT Less CapEx to Interest Expense
-50.52 -125.28 -37.92 -12.72 -50.92 -433.93 0.00 -14.89 -79.79 -458.67 -87.01
NOPAT Less CapEx to Interest Expense
-38.05 -86.88 -39.53 -9.76 -21.93 -324.69 0.00 -12.54 -66.96 -326.26 -70.72
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
106.78% -582.68% -136.83% -19.10% -2.32% -0.73% -0.70% -4.00% -3.16% -7.10% -7.06%
Augmented Payout Ratio
106.78% -582.68% -136.83% -19.10% -2.32% -0.73% -0.70% -4.00% -3.16% -7.10% -7.06%

Financials Breakdown Chart

Key Financial Trends

Zeo Energy’s second-quarter 2026 results show sequential improvement, but the company remains unprofitable and reliant on financing to support cash needs. Revenue increased to $16.2 million from $13.2 million in the first quarter, a 22.6% sequential gain. However, revenue was still 10.7% below the $18.1 million reported in the second quarter of 2025, indicating that the recent recovery has not yet returned the business to prior-year levels.

  • Sequential revenue growth: Q2 revenue rose 22.6% from Q1 2026, while gross profit increased to $7.6 million from $5.6 million. The gross margin also improved to approximately 47.1% from 42.5%.
  • Narrower operating and net losses: Operating loss improved to $3.0 million in Q2 from $4.8 million in Q1, and consolidated net loss narrowed to $2.7 million from $4.7 million. The loss attributable to common shareholders improved to $2.3 million from $3.5 million.
  • Operating cash burn moderated: Cash used in operating activities declined to $461,000 in Q2 from $853,000 in Q1 and $2.3 million in Q2 2025. This reflects better working-capital contributions and a smaller net loss, although operating cash flow remains negative.
  • Cash balance improved during the quarter: Cash and equivalents increased to $2.5 million at June 30, 2026, from $1.7 million at March 31. The increase was supported by $1.4 million of net financing cash flow.
  • Current liquidity is adequate but concentrated in receivables: Current assets of $19.6 million exceeded current liabilities of $12.6 million, implying a current ratio of roughly 1.6. However, cash represented only $2.5 million of current assets, while accounts receivable totaled $10.3 million and prepaid expenses totaled $4.0 million.
  • Gross margins remain volatile: The Q2 2026 gross margin of approximately 47.1% improved sequentially but remained below roughly 59.8% in Q2 2025 and 51.9% in Q4 2025. Sustained margin improvement will be important for the company to reach profitability.
  • Profitability remains distant: Selling, general and administrative expense was $5.9 million and marketing expense was $4.4 million in Q2. Combined, these expenses substantially exceeded gross profit, keeping operating income negative despite the quarterly revenue rebound.
  • Persistent cumulative losses weaken equity quality: Retained earnings were negative $56.4 million at the end of Q2 2026. Goodwill totaled $27.1 million, or approximately 48% of total assets, making the balance sheet more sensitive to potential impairment charges if operating performance deteriorates.
  • Share count has increased substantially: Weighted-average basic shares outstanding rose to 35.2 million in Q2 2026 from 22.1 million in Q2 2025. This roughly 59% increase can dilute existing shareholders and means the company must generate significantly more earnings to improve per-share results.
  • Financing remains important to cash preservation: Zeo generated $1.4 million from financing activities in Q2 while continuing to report negative operating cash flow. If losses and cash burn persist, the company may need additional financing, potentially through debt or equity issuance.

Overall, the latest quarter provides some encouraging evidence of a sequential recovery in sales, margins, losses and cash burn. Nevertheless, Zeo Energy has not yet demonstrated consistent positive operating cash flow or profitability. Investors should focus on whether revenue can regain prior-year levels, whether gross margins stabilize, and whether the company can fund operations without further shareholder dilution.

10/16/26 11:43 PM ETAI Generated. May Contain Errors.

ESGEN Acquisition Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ESGEN Acquisition's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ESGEN Acquisition's net income appears to be on a downward trend, with a most recent value of -$19.63 million in 2025, compared with $14.33 million in 2022. The previous period was -$9.87 million in 2024.

ESGEN Acquisition's total operating income in 2025 was -$20.53 million, based on the following breakdown:
  • Total Gross Profit: $38.28 million
  • Total Operating Expenses: $58.82 million

Over the last 3 years, ESGEN Acquisition's total revenue changed from $0.00 in 2022 to $69.35 million in 2025, a change of 6,934,993,800.0%.

In the past 11 quarters, ESGEN Acquisition's cash and equivalents has ranged from $68.69 thousand in Q2 2025 to $7.73 million in Q1 2024, and is currently $2.45 million as of their latest financial filing in Q2 2026.

ESGEN Acquisition had total debt of $1.28 million at the end of 2025, a 74.2% decrease from 2024, and a 645.3% increase since 2022.

Over the last 3 years, ESGEN Acquisition's book value per share changed from -0.35 in 2022 to 1.21 in 2025.



Financial statements for NASDAQ:ESACW last updated on 8/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners